DENNIS CLARK: Open Payments
NPI 1699700849 · LONG BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$945 in 38 payments from 12 companies in 2025. Trend: 2023 $1,351 · 2024 $1,093 · 2025 $945
Food & beverage: $945
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $291 |
| AstraZeneca Pharmaceuticals LP | 10 | $273 |
| Lilly USA, LLC | 3 | $71 |
| Exact Sciences Corporation | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Neurocrine BioSciences, Inc. | 1 | $37 |
| Amgen Inc. | 1 | $31 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $26 |
Products named: Kerendia, FARXIGA, JARDIANCE, AIRSUPRA, Cologuard Collection Kit, LEQVIO, REXULTI, INGREZZA.
Industry payments across CA — which companies pay providers there.
